Nonmedical prescription drug use comorbidity: Developing a cohesive risk model

Journal of Psychopathology and Behavioral Assessment

Volumn 36, Issue 3, 2014, Pages 371-379

  Ofrat, Shani ^a   Krueger, Robert F ^a   Eaton, Nicholas R ^b   Keyes, Katherine M ^c   Skodol, Andrew E ^c,d   Grant, Bridget F ^e   Hasin, Deborah S ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Comorbidity; Externalizing; Internalizing; Nonmedical prescription drug use

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; NON PRESCRIPTION DRUG; OPIATE; SEDATIVE AGENT; TRANQUILIZER;

ADULT; AGED; ANTISOCIAL BEHAVIOR; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG MISUSE; DYSTHYMIA; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NONMEDICAL PRESCRIPTION DRUG USE; PANIC; SEX DIFFERENCE; SOCIAL PHOBIA; SUBSTANCE ABUSE;

EID: 84905593702     PISSN: 08822689     EISSN: 15733505     Source Type: Journal    
DOI: 10.1007/s10862-014-9409-2     Document Type: Article

References (25)

1. Altman, D. G. (1991). Practical statistics for medical research. London: Chapman and Hall.
2. Arria, A. M., Caldeira, K. M., Vincent, K. B., O'Grady, K. E., & Wish, E. D. (2008). Perceived harmfulness predicts nonmedical use of prescription drugs among college students: Interactions with sensation-seeking. Prevention Science, 9, 191-201.
3. Blanco, C., Alderson, D., Ogburn, E., Grant, B. F., Nunes, E. V., Hatzenbuehler, M. L., et al. (2007). Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug and Alcohol Dependence, 90, 252-260.
4. Centers for Disease Control and Prevention (CDC). (2012). CDC grand rounds: prescription drug overdoses - a U.S. epidemic. Morbidity and Mortality Weekly Report, 61, 10-13.
5. Cheung, G. W., & Rensvold, R. B. (2002). Evaluating goodness-of-fit indexes for testing measurement invariance. Structural Equation Modeling, 9, 233-255.
6. Eaton, N. R., Keyes, K. M., Krueger, R. F., Balsis, S., Skodol, A. E., Markon, K. W., et al. (2012). An invariant dimensional liability model of gender differences in mental disorder prevalence: Evidence from a national sample. Journal of Abnormal Psychology, 121, 282-8.
7. Eaton, N. R., Krueger, R. F., Markon, K. E., Keyes, K. M., Skodol, A. E., Wall, M., et al. (2013). The structure and predictive validity of the internalizing disorders. Journal of Abnormal Psychology, 122, 86-92.
8. Fenton, M. C., Keyes, K. M., Martins, S. S., & Hasin, D. S. (2010). The role of a prescription in anxiety medication use, abuse, and dependence. American Journal of Psychiatry, 167, 1247-1253.
9. Goldstein, S. (2008). Report from the National Survey on Drug Use and Health: nonmedical stimulant use, other drug use, delinquent behaviors, and depression among adolescents. Journal of Attention Disorders, 12, 3.
10. Grant, B. F., Harford, T. C., Dawson, D. A., Chou, P. S., & Pickering, R. P. (1995). The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug and Alcohol Dependence, 39, 37-44.
11. Grant, B. F., Stinson, F. S., Dawson, D. A., & Chou, S. P. (2004). Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders. Archives of General Psychiatry, 61, 807-816.
12. Gros, D. F., Milanak, M. E., Brady, K. T., & Back, S. E. (2013). Frequency and severity of comorbid mood and anxiety disorders in prescription opioid dependence. American Journal on Addictions, 22(3), 261-5.
13. Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1-55.
14. Huang, B., Dawson, D. A., Stinson, F. S., Hasin, D. S., Ruan, W. J., Saha, T. D., et al. (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67, 1062-1073.
15. Jamison, R. N., Butler, S. F., Budman, S. H., Edwards, R. R., & Wasan, A. D. (2010). Gender differences in risk factors for aberrant prescription opioid use. The Journal of Pain: Official Journal of the American Pain Society, 11, 312-20.
16. Krueger, R. F., Caspi, A., Moffitt, T. E., & Silva, P. A. (1998). The structure and stability of common mental disorders (DSM-III-R): a longitudinal-epidemiological study. Journal of Abnormal Psychology, 107, 216-227.
17. Krueger, R. F., Markon, K. E., Patrick, C. J., & Iacono, W. G. (2005). Externalizing psychopathology in adulthood: a dimensional spectrum conceptualization and its implications for DSM-V. Journal of Abnormal Psychology, 114, 537-550.
18. Markon, K. E., & Krueger, R. F. (2005). Categorical and continuous models of liability to externalizing disorders. Archives of General Psychiatry, 62, 1352-1359.
19. Martins, S., Fenton, M., Keyes, K. M., Blanco, C., Zhu, H., & Storr, C. L. (2012). Mood/Anxiety disorders and their association with nonmedical prescription opioid use and prescription opioid use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychological Medicine, 42, 1261-1272.
20. McCabe, S. E. (2005). Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of US college students. Drug and Alcohol Dependence, 79, 53-62.
21. McCabe, S. E., Cranford, J. A., Morales, M., & Young, A. (2006). Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences. Journal of Studies on Alcohol, 67, 529-537.
22. Muthén, L. K., & Muthén, B. O. (2010). Mplus user's guide (5th ed.). Los Angeles: Muthén & Muthén.
23. Simoni-Wastila, L. J. (1998). Gender and psychotropic drug use. Medical Care, 36, 88-94.
24. Simoni-Wastila, L., Ritter, G., & Strickler, G. (2004). Gender and other factors associated with the nonmedical use of abusable prescription drugs. Substance Use and Misuse, 39, 1-23.
25. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings, appendix G. Rockville: US Department of Health and Human Services.